Cargando…
Intranasal Delivery of Recombinant AAV Containing BDNF Fused with HA2TAT: a Potential Promising Therapy Strategy for Major Depressive Disorder
Depression is a disturbing psychiatric disease with unsatisfied therapy. Not all patients are sensitive to anti-depressants currently in use, side-effects are unavoidable during therapy, and the cases with effectiveness are always accompanied with delayed onset of clinical efficacy. Delivering brain...
Autores principales: | Ma, Xian-cang, Liu, Peng, Zhang, Xiao-ling, Jiang, Wen-hui, Jia, Min, Wang, Cai-xia, Dong, Ying-ying, Dang, Yong-hui, Gao, Cheng-ge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776097/ https://www.ncbi.nlm.nih.gov/pubmed/26935651 http://dx.doi.org/10.1038/srep22404 |
Ejemplares similares
-
A Study of Antidepressant Effect and Mechanism on Intranasal Delivery of BDNF-HA2TAT/AAV to Rats with Post-Stroke Depression
por: Chen, Ce, et al.
Publicado: (2020) -
Antidepressant effect of recombinant NT4-NAP/AAV on social isolated mice through intranasal route
por: Liu, Fei, et al.
Publicado: (2016) -
One single method to produce native and Tat-fused recombinant human α-synuclein in Escherichia coli
por: Caldinelli, Laura, et al.
Publicado: (2013) -
Tat-Fused Recombinant Human SAG Prevents Dopaminergic Neurodegeneration in a MPTP-Induced Parkinson’s Disease Model
por: Sohn, Eun Jeong, et al.
Publicado: (2014) -
Chimeric Peptide Tat-HA-NR2B9c Improves Regenerative Repair after Transient Global Ischemia
por: Zhou, Hai-Hui, et al.
Publicado: (2017)